Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
This study is currently recruiting participants.
Study NCT00082862
Information provided by National Cancer Institute (NCI)
First Received: May 14, 2004
Last Updated: April 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
